Serial viral passage and reverse genetics protocol for identifying the antiviral drug targets of EV-D68 antivirals

Research output: Contribution to journalArticlepeer-review

Abstract

Identifying antiviral targets and mechanisms is crucial for drug discovery. Here, we present a protocol to select EV-D68 variants resistant to Jun6504 by combining serial passage and reverse genetics. We describe steps for viral serial passage, sequencing, and viral genome mutagenesis. We then detail procedures for producing and characterizing recombinant viruses. This protocol provides a robust strategy to identify targets from phenotypic screening hits.

Original languageEnglish (US)
Article number104053
JournalSTAR Protocols
Volume6
Issue number3
DOIs
StatePublished - Sep 19 2025
Externally publishedYes

Keywords

  • Chemistry
  • Microbiology
  • Molecular Biology

ASJC Scopus subject areas

  • General Neuroscience
  • General Immunology and Microbiology
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Serial viral passage and reverse genetics protocol for identifying the antiviral drug targets of EV-D68 antivirals'. Together they form a unique fingerprint.

Cite this